Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug2244 | MR or M-M-R II ® vaccine Wiki | 0.71 |
| drug2022 | Isoquercetin (IQC-950AN) Wiki | 0.71 |
| drug2916 | Placebo Wiki | 0.03 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There are 2 clinical trials
As of February 17th, 2020, China has 70635 confirmed cases of coronavirus disease 2019 (COVID-19), including 1772 deaths. Human-to-human spread of virus via respiratory droplets is currently considered to be the main route of transmission. The number of patients increased rapidly but the impact factors of clinical outcomes among hospitalized patients are still unclear.
Description: The primary outcome is the time to negative conversion of coronavirus
Measure: Time to negative conversion of severe acute respiratory syndrome coronavirus 2 Time: 1 monthDescription: The time of hospitalization.
Measure: Length of stay in hospital Time: 1 monthDescription: The rate of survival within hospitalization of these patients will be tracked.
Measure: Survival Time: 1 monthDescription: The rate of intubation within hospitalization of these patients will be tracked.
Measure: Intubation Time: 1 monthAs of February 17th, 2020, China has 70635 confirmed cases of coronavirus disease 2019 (COVID-19), including 1772 deaths. Human-to-human spread of virus via respiratory droplets is currently considered to be the main route of transmission. The number of patients increased rapidly but the impact factors of clinical outcomes among hospitalized patients are still unclear.
Description: The primary outcome is the time to negative conversion of coronavirus
Measure: Time to negative conversion of severe acute respiratory syndrome coronavirus 2 Time: 1 monthDescription: The time of hospitalization
Measure: Length of stay in hospital Time: 1 monthDescription: The rate of survival within hospitalization of these patients will be tracked. The rate of survival within hospitalization of these patients will be tracked. The rate of survival within hospitalization of these patients will be tracked. The rate of survival within hospitalization of these patients will be tracked.
Measure: Survival Time: 1 monthDescription: The rate of intubation within hospitalization of these patients will be tracked
Measure: Intubation Time: 1 monthAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports